Opportunity
SAM #75N98026Q00237
Preclinical Toxicity Testing of Six Novel Drugs by Jai Research Foundation
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
April 21, 2026
Respond By
May 01, 2026
Identifier
75N98026Q00237
NAICS
541715, 541714, 541380
The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), is announcing a procurement for preclinical toxicity testing of six novel drugs. - Government Buyer: - Department of Health and Human Services, National Institutes of Health (NIH) - Office of Logistics and Acquisition Operations (OLAO) - Laboratory of Bioorganic Chemistry - OEMs and Vendors: - Jai Research Foundation (highlighted as the intended awardee and service provider) - Products/Services Requested: - Preclinical toxicity testing for six new novel drugs - Includes safety, solubility, and bioavailability assessments - Testing must follow protocols consistent with previous studies to ensure data comparability - Unique or Notable Requirements: - Continuity with prior testing is required for data consistency - This is the third contract with Jai Research Foundation for similar work - The notice is not a request for competitive quotes, but small businesses may submit capability statements - Place of Performance: - National Institutes of Health facilities in Bethesda, Maryland - Contracting office located at 6011 Executive Blvd., Suite 503L, Bethesda, MD 20892
Description
Attachment: Notice of Intent